What's driving the U.S. Direct-to-Consumer Genetic Testing Market trends? Key players Ancestry, Color Genomics, Easy DNA, Gene By Gene, Helix OpCo LLC, Identigene, Inc., Living DNA Ltd., Pathway genomics
U.S. Direct-To-Consumer Genetic Testing Market is expected to exceed USD 850 million by 2025. Increasing public awareness pertaining to availability of DTC genetic testing kits will be a high impact rendering factor for the U.S. DTC genetic testing market growth.
Request a sample Report of U.S. Direct-to-Consumer Genetic Testing Market at: https://www.marketstudyreport.com/request-a-sample/2276199/?utm_source=OPR.com&utm_medium=SP
Growing demand for personalized DTC genetic testing services will be a high impact rendering factor for U.S. direct-to-consumer genetic testing market. DTC tests are user friendly and provide accurate results. Industry players focus on providing technologically advanced solutions that rises its adoption. For instance, 23andMe manufactures DTC test that utilizes genotype testing technology that provides data on health, carrier status, behavioral attributes for studying drug interactions. Therefore, growing availability of such advanced tests for detection of diseases will spur the industry growth. However, high cost of these kits may hamper the U.S. direct-to-consumer genetic testing market growth to some extent.
Some major findings of the U.S. direct-to-consumer genetic testing market report include:
o U.S. direct to consumer genetic testing industry is in developing stage and is yet to witness numerous growth opportunities with further advancements in technology.
o Benefits associated with DTC genetic tests such as pre-diseases diagnosis that prevents hazardous repercussions has boosted their demand.
o SNP chips is the fastest growing technology and is highly preferred since it provides accurate detection of defective genes in less time.
o The U.S. DTC genetic testing industry is currently dominated by few industry players. Major players operating in the U.S. direct-to-consumer genetic testing market are Ancestry, Color Genomics, 23andMe, FamilytreeDNA (Gene by Gene), Easy DNA, Full Genome, Pathway Genomics and Genesis Healthcare among others. These companies manufacture technologically advanced genetic tests that renders them with competitive advantage.
Rising incidence of genetic diseases will accelerate demand for direct-to-consumer genetic testing kits over the forecast period. Genetic disorders such as achondroplasia, Parkinson?s and Alzheimer?s diseases are amongst the major ailments that cause adverse effect on an individual?s life. Direct access to genetic tests allows patients to know the probability of acquiring such disorders that has reduced the mortality rates. As a result, DTC genetic testing kits have crucial role in recognizing the genetic alterations, thereby escalating its demand in coming years.
Predictive testing segment is anticipated to witness over 16% CAGR throughout the analysis timeframe. Increasing prevalence of genetic diseases will prove beneficial for the U.S. direct-to-genetic testing market growth. Predictive testing helps in detecting the disease before the onset of the disease that in turn will help in reducing the morbidity and mortality rate. Aforementioned factors will escalate the segment growth in near future.
Single nucleotide polymorphism (SNP) chips segment valued for more than USD 140 million in 2018 and it will grow substantially over the forecast period. SNP chips helps in analyzing gene sequences at a particular resolution that reveals detailed analysis regarding defective genes. SNP chips specifically detect changes at molecular level that further increases the efficiency of tests. Therefore, SNP technology is highly preferred during drug discovery process that should augment the segment growth.
Companies are investing in operational activities to offer reliable DTC tests to end-users. Moreover, they are also adopting numerous strategic initiatives such as acquisitions, mergers, product launches, geographical expansions and collaborations to acquire significant market share, sustain the competition and gain competitive advantage over others. For instance, in July 2018, 23andme announced collaboration with GlaxoSmithKline (GSK) company. Collaboration will enable the company to discover therapeutics to treat genetic diseases that enables company to expand its share in the DTC genetic testing market.
Table of Contents:
Chapter 1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
184.108.40.206. Paid sources
220.127.116.11. Unpaid sources
Chapter 2. Executive Summary
2.1. U.S. Direct-To-Consumer (DTC) genetic Testing industry 360 degree synopsis, 2014 - 2025
Chapter 3. U.S. Direct-To-Consumer (DTC) Genetic Testing Industry Insights
Chapter 4. U.S. Direct-To-Consumer (DTC) Genetic Testing Market, By Test Type
Chapter 5. U.S. Direct-To-Consumer (DTC) Genetic Testing Market, By Technology
Chapter 6. U.S. Direct-To-Consumer (DTC) Genetic Testing Market, By Country
Chapter 7. U.S. Direct-To-Consumer (DTC) Genetic Testing Market Company Profiles
Ask for Discount on U.S. Direct-to-Consumer Genetic Testing Market Report at: https://www.marketstudyreport.com/check-for-discount/2276199/?utm_source=OPR.com&utm_medium=SP
Related Reports: https://www.openpr.com/news/1998919/what-s-driving-the-biological-safety-testing-market-size-key
Market Study Report LLC.
4 North Main Street,
Selbyville, Delaware 19975
US Toll Free: 1-866-764-2150
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's driving the U.S. Direct-to-Consumer Genetic Testing Market trends? Key players Ancestry, Color Genomics, Easy DNA, Gene By Gene, Helix OpCo LLC, Identigene, Inc., Living DNA Ltd., Pathway genomics here
News-ID: 2005803 • Views: 243
More Releases from marketstudyreport.com
Covid -19 Impact on Video Conferencing Market Size 2026: Top Companies, Trends a …
Market Study Report recently introduced new title on “2020-2026 Global Video Conferencing Market Report” from its database. The report provides study with in-depth overview, describing about the Product, Industry Scope and elaborates Market size outlook and status to 2026. Video Conferencing Market size is anticipated to grow at over 19% CAGR between 2020 and 2026. The global video conferencing market is set to register a tremendous rise in its growth
What's driving the Patient Monitoring Devices Market Size? Fukuda, Philips, Skan …
Selbyville, Delaware the prime objective of Patient Monitoring Devices report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report. Wireless segment is anticipated to witness more than 5% growth over the forecast period. Substantial growth can be attributed to rising preference for
What's driving the 3D Implants Market trends? Stryker, Smith and Nephew, DJO Glo …
The 3D Implants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Request a sample Report of 3D Implants Market at: https://www.marketstudyreport.com/request-a-sample/2679238/?utm_source=OPR.com/&utm_medium=SP The most likely (base case) scenario
Artificial Vascular Implants Market is thriving worldwide by 2025 | Top Key Play …
Global Artificial Vascular Implants Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Artificial Vascular Implants Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Artificial Vascular Implants market and provides information regarding the revenue for the period 2020 to 2025. The Artificial Vascular Implants market report provides
More Releases for Gene
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal
Gene Therapy Market, by Gene Therapy Type Germline Gene Therapy and Somatic Gene …
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Gene Synthesis Market Size 2017-2022 OriGene, Gene Oracle, Genescript
e Global Gene Synthesis Market Research Report 2016 is a professional and in-depth study on the current state of the Gene Synthesis market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a six-year historic analysis is provided for these markets. The Global market for Gene Synthesis is expected to reach about 410 million USD by 2022 from 200 million USD in 2017, registering a compounded
Gene Therapy Drug Pipeline Analysis
“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight
Cancer Gene Therapy Market Analysis
The gene therapy market has undergone series of transformation from the initial days of research to current clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus of the researchers rapidly shifted towards the cancer. The increasing popularity of cancer therapeutics as a major interest for gene therapy applications led to it accounting for a dominant
Global Gene Editing Technologies Market
Gene editing with engineered nucleases is anticipated to contribute significantly to the global life sciences industry. Gene editing provides application from studying gene functions in plants and animals to gene therapy in humans. Gene editing has more efficiency than many other methods in reverse genetics. Increased development of genetic engineering and increased funding in the field of gene editing is anticipated to drive the growth of the global gene editing